153 related articles for article (PubMed ID: 30866687)
21. Postprocedural Troponin Elevation and Mortality After Transcatheter Aortic Valve Implantation.
Schindler M; Stöckli F; Brütsch R; Jakob P; Holy E; Michel J; Manka R; Vogt P; Templin C; Kasel M; Ruschitzka F; Stähli BE
J Am Heart Assoc; 2021 Nov; 10(21):e020739. PubMed ID: 34713705
[TBL] [Abstract][Full Text] [Related]
22. Elevated growth differentiation factor 15 levels predict outcome in patients undergoing transcatheter aortic valve implantation.
Krau NC; Lünstedt NS; Freitag-Wolf S; Brehm D; Petzina R; Lutter G; Bramlage P; Dempfle A; Frey N; Frank D
Eur J Heart Fail; 2015 Sep; 17(9):945-55. PubMed ID: 26230285
[TBL] [Abstract][Full Text] [Related]
23. Prognostic Implications of Pre-Procedural High-Sensitivity Cardiac Troponin T in Patients Undergoing Transcatheter Aortic Valve Replacement.
Kofler M; Reinstadler SJ; Stastny L; Dumfarth J; Reindl M; Wachter K; Rustenbach CJ; Müller S; Feuchtner G; Mende M; Friedrich G; Metzler B; Grimm M; Bonaros N; Baumbach H
JACC Cardiovasc Interv; 2017 Nov; 10(22):2345-2346. PubMed ID: 29169507
[No Abstract] [Full Text] [Related]
24. Impact of aortic annulus size on valve hemodynamics and clinical outcomes after transcatheter and surgical aortic valve replacement: insights from the PARTNER Trial.
Rodés-Cabau J; Pibarot P; Suri RM; Kodali S; Thourani VH; Szeto WY; Svensson LG; Dumont E; Xu K; Hahn RT; Leon MB
Circ Cardiovasc Interv; 2014 Oct; 7(5):701-11. PubMed ID: 25270901
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and Prognostic Significance of Right Ventricular Systolic Dysfunction in Patients Undergoing Transcatheter Aortic Valve Implantation.
Lindsay AC; Harron K; Jabbour RJ; Kanyal R; Snow TM; Sawhney P; Alpendurada F; Roughton M; Pennell DJ; Duncan A; Di Mario C; Davies SW; Mohiaddin RH; Moat NE
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27418610
[TBL] [Abstract][Full Text] [Related]
26. The impact of the development of transcatheter aortic valve implantation on the management of severe aortic stenosis in high-risk patients: treatment strategies and outcome.
Bouleti C; Chauvet M; Franchineau G; Himbert D; Iung B; Alos B; Brochet E; Urena M; Ghodbane W; Ou P; Provenchere S; Nataf P; Vahanian A
Eur J Cardiothorac Surg; 2017 Jan; 51(1):80-88. PubMed ID: 27582074
[TBL] [Abstract][Full Text] [Related]
27. A comparison of conventional surgery, transcatheter aortic valve replacement, and sutureless valves in "real-world" patients with aortic stenosis and intermediate- to high-risk profile.
Muneretto C; Alfieri O; Cesana BM; Bisleri G; De Bonis M; Di Bartolomeo R; Savini C; Folesani G; Di Bacco L; Rambaldini M; Maureira JP; Laborde F; Tespili M; Repossini A; Folliguet T
J Thorac Cardiovasc Surg; 2015 Dec; 150(6):1570-7; discussion 1577-9. PubMed ID: 26384753
[TBL] [Abstract][Full Text] [Related]
28. Impact of Preprocedural B-Type Natriuretic Peptide Levels on the Outcomes After Transcatheter Aortic Valve Implantation.
Abramowitz Y; Chakravarty T; Jilaihawi H; Lee C; Cox J; Sharma RP; Mangat G; Cheng W; Makkar RR
Am J Cardiol; 2015 Dec; 116(12):1904-9. PubMed ID: 26602075
[TBL] [Abstract][Full Text] [Related]
29. The prognostic value of acute and chronic troponin elevation after transcatheter aortic valve implantation.
Sinning JM; Hammerstingl C; Schueler R; Neugebauer A; Keul S; Ghanem A; Mellert F; Schiller W; Müller C; Vasa-Nicotera M; Zur B; Welz A; Grube E; Nickenig G; Werner N
EuroIntervention; 2016 Apr; 11(13):1522-9. PubMed ID: 25671517
[TBL] [Abstract][Full Text] [Related]
30. Identification of Periprocedural Myocardial Infarction Using a High-Sensitivity Troponin I Assay in Patients Who Underwent Transcatheter Aortic Valve Implantation.
Liebetrau C; Kim WK; Meyer A; Arsalan M; Gaede L; Blumenstein JM; Fischer-Rasokat U; Wolter JS; Dörr O; Schillinger S; Troidl C; Nef HM; Hamm CW; Walther T; Möllmann H
Am J Cardiol; 2017 Oct; 120(7):1180-1186. PubMed ID: 28826900
[TBL] [Abstract][Full Text] [Related]
31. Prognostic Relevance of Left Ventricular Myocardial Performance After Transcatheter Aortic Valve Replacement.
Asami M; Pilgrim T; Lanz J; Heg D; Franzone A; Piccolo R; Langhammer B; Praz F; Räber L; Valgimigli M; Roost E; Windecker S; Stortecky S
Circ Cardiovasc Interv; 2019 Jan; 12(1):e006612. PubMed ID: 30626203
[TBL] [Abstract][Full Text] [Related]
32. The changing characteristics and outcomes of patients undergoing surgical aortic valve replacement in the transcatheter aortic valve implantation era.
Rozen G; Fefer P; Shinfeld A; Sternik L; Guetta V; Malachy A; Levin S; Feinberg M; Raanani E; Segev A
J Cardiovasc Med (Hagerstown); 2015 Apr; 16(4):261-6. PubMed ID: 25004001
[TBL] [Abstract][Full Text] [Related]
33. Effect of Baseline Left Ventricular Ejection Fraction on 2-Year Outcomes After Transcatheter Aortic Valve Replacement: Analysis of the PARTNER 2 Trials.
Furer A; Chen S; Redfors B; Elmariah S; Pibarot P; Herrmann HC; Hahn RT; Kodali S; Thourani VH; Douglas PS; Alu MC; Fearon WF; Passeri J; Malaisrie SC; Crowley A; McAndrew T; Genereux P; Ben-Yehuda O; Leon MB; Burkhoff D
Circ Heart Fail; 2019 Aug; 12(8):e005809. PubMed ID: 31525069
[TBL] [Abstract][Full Text] [Related]
34. Impact of preprocedural mesenteric artery stenosis and mesenteric ischemia in patients undergoing transcatheter aortic valve replacement.
Chen JH; Chen YH; Chang HH; Leu HB; Chen IM; Chen PL; Lin SM
J Thorac Cardiovasc Surg; 2022 Nov; 164(5):1458-1471.e6. PubMed ID: 35469598
[TBL] [Abstract][Full Text] [Related]
35. Impact of pre-procedural serum albumin levels on outcome of patients undergoing transcatheter aortic valve replacement.
Koifman E; Magalhaes MA; Ben-Dor I; Kiramijyan S; Escarcega RO; Fang C; Torguson R; Okubagzi P; Negi SI; Baker NC; Minha S; Corso PJ; Shults C; Satler LF; Pichard AD; Waksman R
Am J Cardiol; 2015 May; 115(9):1260-4. PubMed ID: 25759105
[TBL] [Abstract][Full Text] [Related]
36. Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE-2 registry.
Puymirat E; Didier R; Eltchaninoff H; Lung B; Collet JP; Himbert D; Durand E; Leguerrier A; Leprince P; Fajadet J; Teiger E; Chevreul K; Lièvre M; Tchetché D; Leclercq F; Chassaing S; Le Breton H; Donzeau-Gouge P; Lefèvre T; Carrié D; Gillard M; Blanchard D
Clin Cardiol; 2017 Dec; 40(12):1316-1322. PubMed ID: 29247516
[TBL] [Abstract][Full Text] [Related]
37. Serum albumin in patients undergoing transcatheter aortic valve replacement: A meta-analysis.
Hsieh WC; Aboud A; Henry BM; Omara M; Lindner J; Pirk J
Rev Cardiovasc Med; 2019 Sep; 20(3):161-169. PubMed ID: 31601090
[TBL] [Abstract][Full Text] [Related]
38. Association between valvuloarterial impedance after transcatheter aortic valve implantation and 2-year mortality in elderly patients with severe symptomatic aortic stenosis: the OCEAN-TAVI registry.
Nagura F; Kataoka A; Hara M; Kozuma K; Watanabe Y; Nakashima M; Hioki H; Kawashima H; Nara Y; Shirai S; Tada N; Araki M; Naganuma T; Yamanaka F; Ueno H; Tabata M; Mizutani K; Higashimori A; Takagi K; Yamamoto M; Hayashida K;
Heart Vessels; 2019 Jun; 34(6):1031-1039. PubMed ID: 30599060
[TBL] [Abstract][Full Text] [Related]
39. Aortic regurgitation following transcatheter aortic valve replacement: Impact of preprocedural left ventricular diastolic filling patterns on late clinical outcomes.
Halkin A; Steinvil A; Aviram G; Biner S; Banai S; Keren G; Finkelstein A; Topilsky Y
Catheter Cardiovasc Interv; 2016 May; 87(6):1156-63. PubMed ID: 26526673
[TBL] [Abstract][Full Text] [Related]
40. Minimally invasive versus transapical versus transfemoral aortic valve implantation: A one-to-one-to-one propensity score-matched analysis.
Furukawa N; Kuss O; Emmel E; Scholtz S; Scholtz W; Fujita B; Ensminger S; Gummert JF; Börgermann J
J Thorac Cardiovasc Surg; 2018 Nov; 156(5):1825-1834. PubMed ID: 29861110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
